FDA approvals in 2025 introduced novel therapies and devices across ophthalmic subspecialties, emphasizing sustained efficacy ...
The PRIMA system is a subretinal implant designed to restore central vision in GA patients by replacing failed photoreceptors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback